Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Nephrolithiasis
What is your approach for stone prevention for patients with recurrent nephrolithiasis who are started on GLP-1 agonist therapy and subsequently consume less daily water intake?
Related Questions
What is your approach to patients with recurrent nephrolithiasis and low urine volumes who struggle with increasing fluid intake following a sleeve gastrectomy procedure?
Would you refer a patient for kidney only or kidney and liver transplantation if they develop advanced chronic kidney disease secondary to primary hyperoxaluria type 2?
Are there instances when you recommend kidney stone disorder gene testing in patients suspected of having cystinuria?
Would you start allopurinol for a patient with uric acid kidney stones who does not have hyperuricemia or hyperuricosuria?
Do you recommend treating asymptomatic Proteus urinary infections in patients with alkaline urine and recurrent calcium phosphate nephrolithiasis?
Would you recommend off-label use of nedosiran for patients with primary hyperoxaluria type 2?
Is there a kidney stone size for which you refer your patients with recurrent nephrolithiasis to urology?
Would you avoid potassium citrate initiation in a pregnant patient with hypocitraturia and recurrent calcium oxalate nephrolithiasis?
Are there instances when you recommend oral phosphate for patients with recurrent nephrolithiasis?
How do you advise your patients with recurrent nephrolithiasis to avoid consuming more than usual fluid volume on the day of a scheduled 24 hour urine stone risk study?
